HER2-positive and ER- and PgR-negative cancers tended to give rise first to liver metastases more frequently compared with the other subtypes (in 13 (27.1%) of 48 vs. 44 (16.1%) of 273 first distant sites the site was in the liver, P = 0.067). This evidence concerns the gene EREG and cancer.